当前位置:首页 > 期刊 > 《医药产业资讯》 > 2015年第24期 > 正文
编号:12588142
多发性骨髓瘤伴椎管浸润2例(1)
http://www.100md.com 2015年8月25日 中国医药导报2015年第24期
     [摘要] 多发性骨髓瘤(MM)伴椎管浸润临床罕见,治疗困难,目前国内外尚无推荐的标准治疗方案,仅见个案报道,预后差。化疗、手术、放疗为基本的治疗手段。本文总结分析2例MM伴椎管浸润病例的临床诊疗过程、疗效及病程的进展情况,并复习相关文献,进一步加深对MM伴椎管浸润的诊疗认识。及早发现、诊断和个体化治疗是改善预后的关键,患者一旦出现截瘫,治疗效果差,进展迅速,预后极差。

    [关键词] 多发性骨髓瘤;椎管浸润;化疗;手术;放疗

    [中图分类号] R733.3 [文献标识码] A [文章编号] 1673-7210(2015)08(c)-0153-05

    [Abstract] Multiple myeloma (MM) with intraspinal invasion is very rare in clinic, which is difficult to treat. No standard treatments are recommended at home and abroad, and only case report can be found, which is poor prognostic. Chemotherapy, operation and radiotherapy are the basic treatments. To further deepen the understanding of the diagnosis and treatment of MM complicated by spinal infiltration ......
1 2 3 4下一页

您现在查看是摘要页,全文长 5471 字符